@article{JTD18523,
author = {Linda Agolli and Stefano Arcangeli},
title = {Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {2},
year = {2018},
keywords = {},
abstract = {Lung cancer is associated with the worst cancer-specific survival than any other tumor. Most of the patients with non-small cell lung cancer (NSCLC) are diagnosed in IV Stage or will develop metastatic progression during the course of the disease (1). A paucity of treatments warrant durable survival benefits once the tumor has spread over the lungs, likely due to the aggressive nature and the ability to progress.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/18523}
}